Ritlecitinib 53869-0334
Product NDC
53869-0334- Manufacturer
- Pfizer Manufacturing Deutschland Gmbh
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- June 13, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ritlecitinib Tosylate | 50 mg/1 |
Packaging Options(1)
48 BOTTLE in 1 CASE (53869-0334-6) / 28 CAPSULE in 1 BOTTLE (53869-0334-5)